Dr. Scott A Laurie
Claim this profileThe Ottawa Hospital
Area of expertise
Cancer
Scott A Laurie has run 3 trials for Cancer. Some of their research focus areas include:
Solid Tumors
Scott A Laurie has run 3 trials for Solid Tumors. Some of their research focus areas include:
Affiliated Hospitals
The Ottawa Hospital
Ottawa Hospital Research Institute
Clinical Trials Scott A Laurie is currently running
Durvalumab (+/- Tremelimumab)
for Cancer
I238A: The purpose of this study is to find out what effects being treated with durvalumab has on cancer. The researchers doing this study also want to evaluate if prednisone (a type of steroid), when given together with durvalumab, can reduce any side effects. I238B: The purpose of this study is to allow patients previously enrolled on a completed CCTG trial to continue treatment with durvalumab (+/- tremelimumab)
Recruiting
1 award
Phase 2
15 criteria
YL211
for Cancer
This is a multicenter, open-label, Phase 1 study. The study will enroll subjects with advanced solid tumors. It consists of three parts. Part 1 is dose-escalation part. In part 1, the safety and tolerability of YL211 in patients with selected advanced solid tumors will be evaluated and the MTD and RED will be determined. Part 2 is backfill enrollment part. We will further estimate the safety and efficacy of YL211 in patients with selected adcance tumor to select the RED(s) of YL211. Part 3 is dose-expansion part. In this part, we will further evaluate the safety and efficacy of YL211 at the MTD/RED(s) in patients with selected advanced solid tumors YL211 will be administered intravenously (IV) until criteria of treatment discontinuation are met.
Recruiting
1 award
Phase 1
2 criteria
More about Scott A Laurie
Clinical Trial Related
5 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Scott A Laurie has experience with
- BI 907828
- CFI-402411
- Pembrolizumab
- YL211
- Durvalumab
- Prednisone
Breakdown of trials Scott A Laurie has run
Cancer
Solid Tumors
Lung Cancer
Cervical Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Scott A Laurie specialize in?
Scott A Laurie focuses on Cancer and Solid Tumors. In particular, much of their work with Cancer has involved MDM2 positive patients, or patients who are Stage IV.
Is Scott A Laurie currently recruiting for clinical trials?
Yes, Scott A Laurie is currently recruiting for 2 clinical trials in Ottawa Ontario. If you're interested in participating, you should apply.
Are there any treatments that Scott A Laurie has studied deeply?
Yes, Scott A Laurie has studied treatments such as BI 907828, CFI-402411, Pembrolizumab.
What is the best way to schedule an appointment with Scott A Laurie?
Apply for one of the trials that Scott A Laurie is conducting.
What is the office address of Scott A Laurie?
The office of Scott A Laurie is located at: The Ottawa Hospital, Ottawa, Ontario K1H 8L6 Canada. This is the address for their practice at the The Ottawa Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.